Education
About Us
Working with TipRanks
Follow Us
OS Therapies Incorporated (OSTX)
:OSTX
RESEARCH TOOLSreports
OSTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.41 - $7.00
Previous CloseN/A
Volume28.07K
Average Volume (3M)1.50M
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$80.79K
Total Debt (Recent Filing)$7.07M
Price to Earnings (P/E)―
Beta-1.38
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.43
Shares Outstanding21,765,303
10 Day Avg. Volume103,233
30 Day Avg. Volume1,497,115
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$15.00Price Target Upside767.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Bulls Say, Bears Say
Bulls Say
Clinical TrialsOSTX announced positive P2b top-line data for OST-HER2 in recurrent osteosarcoma, meeting the primary endpoint of 12-month event free survival.
Financial OutlookOn the positive outcome and potential for accelerated approval, the revenue risk adjustment was lowered, increasing the 12-month price target to $15.
Regulatory ApprovalThe positive data positions the company to meet with the FDA to discuss the potential for filing for accelerated approval.
Bears Say
Cash ReservesThe company has $1.8M in cash and a $15M equity line, which, combined, should provide runway into 1H26, excluding monetization of non-core programs.
---
Options Prices
Currently, No data available
---
Ownership Overview
28.55% Insiders
0.51% Other Institutional Investors
70.93% Public Companies and
Individual Investors
OSTX FAQ
What was OS Therapies Incorporated’s price range in the past 12 months?
OS Therapies Incorporated lowest stock price was $1.41 and its highest was $7.00 in the past 12 months.
What is OS Therapies Incorporated’s market cap?
Currently, no data Available
When is OS Therapies Incorporated’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were OS Therapies Incorporated’s earnings last quarter?
Currently, no data Available
Is OS Therapies Incorporated overvalued?
According to Wall Street analysts OS Therapies Incorporated’s price is currently Undervalued.
Does OS Therapies Incorporated pay dividends?
OS Therapies Incorporated does not currently pay dividends.
What is OS Therapies Incorporated’s EPS estimate?
OS Therapies Incorporated’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OS Therapies Incorporated have?
OS Therapies Incorporated has 21,765,303 shares outstanding.
What happened to OS Therapies Incorporated’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of OS Therapies Incorporated?
Currently, no hedge funds are holding shares in OSTX
---
Company Description
OS Therapies Incorporated
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.
---
OSTX Stock 12 Month Forecast
Average Price Target
$15.00
▲(767.05% Upside)
Technical Analysis
Karyopharm Therapeutics
―
Abeona Therapeutics
―
Cyclerion Therapeutics
―
ADC Therapeutics
―
Best Analysts Covering OSTX
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-35.75%
reiterated a buy rating 2 months ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -35.75% per trade.
---